FDA Adverse Event Injury Summary report: N

KAMRA

MDR report key: 5125630 · Received October 2, 2015

Report

Report Number
3008401069-2015-00002
Event Type
Injury
Date Received
October 2, 2015
Date of Event
January 9, 2015
Report Date
April 22, 2016
Manufacturer
ACUFOCUS, INC.
Product Code
LQE
PMA / PMN Number
P120023
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
EI
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE REASON FOR EXPLANTATION WAS DUE TO SEVERE LIGHT SENSITIVITY COUPLED WITH INTRAPOCKET DEBRIS RESULTING IN AN INFLAMMATORY REACTION.

Additional Manufacturer Narrative · 1

WE APOLOGIZE FOR THE TIMELINESS OF THIS REPORT; (B)(4) HAS BEEN INITIATED TO INVESTIGATE AND CORRECT THIS ISSUE. DEVICE EVALUATION A REVIEW OF THE DEVICE HISTORY RECORD WAS PERFORMED AND THERE WERE NO DISCREPANCIES NOTED THAT RELATE TO THE EVENT. THE DEVICE WAS RETURNED TO ACUFOCUS, INC. ON JUNE 12, 2015. A VISUAL ANALYSIS FOUND THE INLAY WAS SEVERELY FOLDED, WHERE ACCURATE MEASUREMENTS COULD NOT BE TAKEN. THE NOTED DAMAGE IS CONSISTENT WITH THAT OF AN EXPLANTED INLAY AND DUE TO DAMAGE DURING HANDLING FROM THE EXPLANT PROCEDURE. HENCE, WE CANNOT ATTRIBUTE THE RECEIPT CONDITION OF THE INLAY TO THE DEVICE. ACUFOCUS, INC. DOES NOT BELIEVE THE ALLEGED EVENT TO BE MANUFACTURING PROCESS AND/OR DEVICE RELATED. THE COMPLAINT TRENDS WILL CONTINUE TO BE MONITORED AND ACTION TAKEN IF DEEMED REQUIRED. ALL (B)(4) UNITS PRODUCED AS LOT A518-1213 HAVE BEEN DISTRIBUTED AND NO OTHER COMPLAINTS OF INFLAMMATION WERE REPORTED FOR THIS LOT. THEREFORE, THE ALLEGED EVENT IS NOT BELIEVED TO BE LOT RELATED. FURTHERMORE, BASED ON THE REPORTED INFORMATION, THE CAUSE OF THE INFLAMMATORY REACTION MAY POTENTIALLY BE RELATED TO THE INTRA POCKET DEBRIS.

Description of Event or Problem · 1

ON JUNE 11, 2015, ACUFOCUS, INC. BECAME AWARE THAT THE KAMRA CORNEAL INLAY WAS EXPLANTED 45 DAYS POSTOPERATIVELY DUE TO AN INFLAMMATORY RESPONSE TO THE INLAY AND SOME INTRA POCKET DEBRIS ON THE NASAL SIDE OF THE INLAY. AS SUCH, THE INLAY WAS SIGNIFICANTLY INFERIORLY DISPLACED.

Description of Event or Problem · 1

ON (B)(6) 2015, ACUFOCUS INC., BECAME AWARE THAT THE KAMRA CORNEAL INLAY WAS EXPLANTED 45 DAYS POSTOPERATIVELY DUE TO AN INFLAMMATORY RESPONSE TO THE INLAY AND SOME INTRAPOCKET DEBRIS ON THE NASAL SIDE OF THE INLAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
653567 KAMRA CORNEAL INLAY LQE ACUFOCUS, INC. ACI 7000 A518-1213

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention